Efficacy and safety of evogliptin in patients with type 2 diabetes and non-alcoholic fatty liver disease: A multicentre, double-blind, randomized, comparative trial.
Eugene HanJi Hye HuhEun Y LeeJi C BaeSung W ChunSung H YuSoo H KwakKyong S ParkByung-Wan LeePublished in: Diabetes, obesity & metabolism (2021)